SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-007736
Filing Date
2021-04-27
Accepted
2021-04-27 16:17:34
Documents
15
Period of Report
2021-04-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K auph-20210427.htm   iXBRL 8-K 44896
2 EX-3.2 AMENDED AND RESTATED BY-LAW AS OF APRIL 23, 2021 exhibit32amendedandrestate.htm EX-3.2 219954
  Complete submission text file 0001628280-21-007736.txt   453791

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210427.xsd EX-101.SCH 2451
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210427_cal.xml EX-101.CAL 732
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210427_def.xml EX-101.DEF 1669
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210427_lab.xml EX-101.LAB 24977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210427_pre.xml EX-101.PRE 13209
8 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210427_htm.xml XML 11590
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 21859143
SIC: 2834 Pharmaceutical Preparations